Complaint·June 13, 2023

Licensing Program Analyst Leibert arrived unannounced for the purpose of delivering findings on the above captioned complaint. LPA met with Res. Care Director and discussed the allegation. During the course of this investigation this Department has interviewed witness and staff; obtained and reviewed documents; made site visits to the facility. Based on these actions, the following determinations are made: Complainant alleges that R1 was not administered prescription eye drops on several occasions while in residence at the facility; The Medication Administration Record for R1 indicates missed doses of eye drops on 3 occasions in April and on 4 occasions in March, 2023; Facility Administration states that the doses were administered but that they were inadvertently not documented on the Medication Administration Record. Based upon the statements taken and the documents reviewed, the preponderance of evidence standard has been met. Therefore, the allegation is SUBSTANTIATED. The following deficiencies were observed (see LIC 9099D) and cited from the California Code of Regulations, Title 22, Division 6 of California Regulation. Failure to correct the deficiency and/or repeat deficiencies within a 12 month period may result in civil penalties. Exit interview conducted and appeal of rights provided. Report left.